Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- 0 vs. Q2 2022
- Shares held
- 58.8M
- +541.4K (+0.9%) vs. Q2 2022
- Total value
- $1.27B
- −$363.4M (−22.2%) vs. Q2 2022
- New holders
- 21
- 47 more added
- Sold out
- 21
- 36 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtus ETF Advisers LLC | 4,819 | $104.0K | 0.04% | +33+0.7% | Added |
| Quantbot Technologies LP | 3,900 | $84.0K | 0.01% | −3,747−49.0% | Reduced |
| Ameritas Investment Partners, Inc. | 3,681 | $79.0K | 0.00% | +929+33.8% | Added |
| Metropolitan Life Insurance Co | 2,828 | $61.3K | 0.00% | +550+24.1% | Added |
| Point72 Hong Kong Ltd | 2,740 | $59.0K | 0.00% | +2,740 | New |
| Great West Life Assurance Co | 2,211 | $48.0K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1,382 | $42.0K | 0.00% | +14+1.0% | Added |
| Nisa Investment Advisors, LLC | 1,238 | $31.0K | 0.00% | +38+3.2% | Added |
| Royal Bank of Canada | 597 | $13.0K | 0.00% | −13,956−95.9% | Reduced |
| China Universal Asset Management Co., Ltd. | 534 | $12.0K | 0.01% | +534 | New |
| Macquarie Group Ltd | 0 | $6.00K | 0.00% | −272−100.0% | Reduced |
| Daiwa Securities Group Inc. | 212 | $5.00K | 0.00% | 00.0% | Unchanged |
| Proequities, Inc. | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 85 | $2.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 97 | $2.00K | 0.00% | +12+14.1% | Added |
| Ronald Blue Trust, Inc. | 84 | $2.00K | 0.00% | +84 | New |
| Bell Investment Advisors, Inc | 76 | $2.00K | 0.00% | +76 | New |
| US Bancorp | 28 | $1.00K | 0.00% | −1,248−97.8% | Reduced |
| Allworth Financial LP | 7 | $0 | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 34 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 6 | $0 | 0.00% | −4−40.0% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 0 | $0 | 0.00% | −2,026,656−100.0% | Sold out |
| Fiera Capital Corp | 0 | $0 | 0.00% | −362,584−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −38,342−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −28,886−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −15,050−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −13,880−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −10,462−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −10,073−100.0% | Sold out |
| Birchview Capital, LP | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −7,620−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −7,298−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −1,054−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −962−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −581−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −484−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −285−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Moisand Fitzgerald Tamayo, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Fieldpoint Private Securities, LLC | – | – | – | – | Not filed |